Donald K. Baker

1.6k total citations
29 papers, 1.2k citations indexed

About

Donald K. Baker is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Pharmacology. According to data from OpenAlex, Donald K. Baker has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 6 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Donald K. Baker's work include Pharmacogenetics and Drug Metabolism (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Pharmaceutical studies and practices (6 papers). Donald K. Baker is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Pharmaceutical studies and practices (6 papers). Donald K. Baker collaborates with scholars based in United States, Germany and Czechia. Donald K. Baker's co-authors include James M. Hoffman, Mary V. Relling, Kristine R. Crews, Scott C. Howard, William E. Evans, Ulrich Broeckel, Cyrine E. Haidar, Mark R. Wilkinson, Shane J. Cross and Wenjian Yang and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Geochimica et Cosmochimica Acta.

In The Last Decade

Donald K. Baker

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald K. Baker United States 17 461 445 240 230 151 29 1.2k
Brian S. Decker United States 18 417 0.9× 520 1.2× 161 0.7× 94 0.4× 92 0.6× 44 1.6k
Samuel G. Johnson United States 18 532 1.2× 281 0.6× 157 0.7× 192 0.8× 137 0.9× 36 1.3k
Nathalie Bleyzac France 23 169 0.4× 321 0.7× 205 0.9× 69 0.3× 235 1.6× 94 1.6k
Pamala A. Jacobson United States 29 293 0.6× 752 1.7× 371 1.5× 100 0.4× 315 2.1× 131 2.6k
Elizabeth Ludwig United States 19 208 0.5× 173 0.4× 119 0.5× 55 0.2× 98 0.6× 59 1.1k
Aniwaa Owusu Obeng United States 14 492 1.1× 304 0.7× 87 0.4× 255 1.1× 156 1.0× 23 1.1k
F Vauzelle-Kervroëdan France 17 109 0.2× 217 0.5× 70 0.3× 75 0.3× 104 0.7× 38 1.3k
Kelly A. Birdwell United States 14 293 0.6× 350 0.8× 139 0.6× 96 0.4× 85 0.6× 34 1.2k
Stein Bergan Norway 26 216 0.5× 653 1.5× 221 0.9× 69 0.3× 324 2.1× 106 2.1k
Kathryn A. Phillips United States 6 282 0.6× 132 0.3× 375 1.6× 128 0.6× 57 0.4× 8 984

Countries citing papers authored by Donald K. Baker

Since Specialization
Citations

This map shows the geographic impact of Donald K. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald K. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald K. Baker more than expected).

Fields of papers citing papers by Donald K. Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald K. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald K. Baker. The network helps show where Donald K. Baker may publish in the future.

Co-authorship network of co-authors of Donald K. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Donald K. Baker. A scholar is included among the top collaborators of Donald K. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald K. Baker. Donald K. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crews, Kristine R., Nancy M. Kornegay, Donald K. Baker, et al.. (2022). Clinician adherence to pharmacogenomics prescribing recommendations in clinical decision support alerts. Journal of the American Medical Informatics Association. 30(1). 132–138. 8 indexed citations
2.
Morris, Sarah, Kristine R. Crews, Randall T. Hayden, et al.. (2021). Incorporating G6PD genotyping to identify patients with G6PD deficiency. Pharmacogenetics and Genomics. 32(3). 87–93. 6 indexed citations
3.
Daniels, Calvin C., Jonathan D. Burlison, Donald K. Baker, et al.. (2019). Optimizing Drug-Drug Interaction Alerts Using a Multidimensional Approach. PEDIATRICS. 143(3). 11 indexed citations
4.
Burlison, Jonathan D., et al.. (2018). Using EHR Data to Detect Prescribing Errors in Rapidly Discontinued Medication Orders. Applied Clinical Informatics. 9(1). 82–88. 4 indexed citations
5.
Gammal, Roseann S., Kristine R. Crews, Cyrine E. Haidar, et al.. (2016). Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease. PEDIATRICS. 138(1). 56 indexed citations
6.
Burlison, Jonathan D., Donald K. Baker, Jennifer Robertson, et al.. (2015). Alert dwell time: introduction of a measure to evaluate interruptive clinical decision support alerts. Journal of the American Medical Informatics Association. 23(e1). e138–e141. 32 indexed citations
7.
Hoffman, James M., Cyrine E. Haidar, Mark R. Wilkinson, et al.. (2014). PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 166(1). 45–55. 205 indexed citations
8.
Burlison, Jonathan D., Jennifer Robertson, Jeffrey R. Scott, et al.. (2014). Adverse Drug Event Detection in Pediatric Oncology and Hematology Patients: Using Medication Triggers to Identify Patient Harm in a Specialized Pediatric Patient Population. The Journal of Pediatrics. 165(3). 447–452.e4. 22 indexed citations
9.
Bell, Gillian C., Kristine R. Crews, Mark R. Wilkinson, et al.. (2013). Development and use of active clinical decision support for preemptive pharmacogenomics. Journal of the American Medical Informatics Association. 21(e1). e93–e99. 159 indexed citations
10.
Hicks, J. Kevin, Kristine R. Crews, James M. Hoffman, et al.. (2012). A Clinician-Driven Automated System for Integration of Pharmacogenetic Interpretations Into an Electronic Medical Record. Clinical Pharmacology & Therapeutics. 92(5). 563–566. 77 indexed citations
11.
12.
Shenep, Jerry L., Patricia M. Flynn, Donald K. Baker, et al.. (2001). Oral Cefixime Is Similar to Continued Intravenous Antibiotics in the Empirical Treatment of Febrile Neutropenic Children with Cancer. Clinical Infectious Diseases. 32(1). 36–43. 65 indexed citations
13.
Bowman, Laura C., et al.. (1998). Algorithm for nutritional support: Experience of the metabolic and infusion support service of St. Jude Children's Research Hospital. International Journal of Cancer. 78(S11). 76–80. 42 indexed citations
14.
Relling, Mary V., et al.. (1993). Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy. The Journal of Pediatrics. 123(5). 811–816. 18 indexed citations
15.
Baker, Donald K., Mary V. Relling, Ching‐Hon Pui, et al.. (1992). Increased teniposide clearance with concomitant anticonvulsant therapy.. Journal of Clinical Oncology. 10(2). 311–315. 50 indexed citations
16.
Friedman, Alice G., Raymond K. Mulhern, Diane Fairclough, et al.. (1991). Midazolam premedication for pediatric bone marrow aspiration and lumbar puncture. Medical and Pediatric Oncology. 19(6). 499–504. 42 indexed citations
17.
Mirro, Joseph, et al.. (1989). Targeted Plasma Drug Concentration: A New Therapeutic Approach to Relapsed Nonlymphoblastic Leukemia in Children. Hämatologie und Bluttransfusion. 32. 82–87. 2 indexed citations
18.
Shenep, Jerry L., Walter T. Hughes, Paula K. Roberson, et al.. (1988). Vancomycin, Ticarcillin, and Amikacin Compared with Ticarcillin-Clavulanate and Amikacin in the Empirical Treatment of Febrile, Neutropenic Children with Cancer. New England Journal of Medicine. 319(16). 1053–1058. 144 indexed citations
19.
Goren, Marshall P., Mary Jane Viar, Jerry L. Shenep, et al.. (1988). Monitoring serum aminoglycoside concentrations in children with amphotericin B nephrotoxicity. The Pediatric Infectious Disease Journal. 7(10). 698–702. 6 indexed citations
20.
Baker, Donald K.. (1966). Geochemistry of sediments—A brief survey. Geochimica et Cosmochimica Acta. 30(3). 363–363. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian S. Decker Breakdown of academic impact, for papers by Samuel G. Johnson Breakdown of academic impact, for papers by Nathalie Bleyzac Breakdown of academic impact, for papers by Pamala A. Jacobson Breakdown of academic impact, for papers by Elizabeth Ludwig Breakdown of academic impact, for papers by Aniwaa Owusu Obeng Breakdown of academic impact, for papers by F Vauzelle-Kervroëdan Breakdown of academic impact, for papers by Kelly A. Birdwell Breakdown of academic impact, for papers by Stein Bergan Breakdown of academic impact, for papers by Kathryn A. Phillips
Rankless by CCL
2026